EMEA-002194-PIP01-17

Key facts

Invented name
Active substance
Opicinumab
Therapeutic area
Neurology
Decision number
P/0369/2017
PIP number
EMEA-002194-PIP01-17
Pharmaceutical form(s)
Solution for injection/infusion
Condition(s) / indication(s)
Treatment of multiple sclerosis
Route(s) of administration
Intravenous use
Contact for public enquiries
Biogen Idec Limited
Tel. +44 1628512586
E-mail: pip.enquiries@biogen.com
Decision type
W: decision granting a waiver in all age groups for all conditions/indications

Decision

How useful was this page?

Add your rating